市場調査レポート：世界の医薬品用中間バルクコンテナ（IBC）市場（～2028年）：ステンレス鋼IBC、ポリエチレンIBC

• 英文タイトル：Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Insights, Forecast to 2028

Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Insights, Forecast to 2028「世界の医薬品用中間バルクコンテナ（IBC）市場（～2028年）：ステンレス鋼IBC、ポリエチレンIBC」（市場規模、市場予測）調査レポートです。

• レポートコード：MRC2Q12-18672
• 出版社/出版日：QYResearch / 2022年12月
• レポート形態：英文、PDF、85ページ
• 納品方法：Eメール（納期：3営業日）
• 産業分類：包装

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、医薬品用中間バルクコンテナ（IBC）のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
医薬品用中間バルクコンテナ（IBC）のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
医薬品用中間バルクコンテナ（IBC）の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
医薬品用中間バルクコンテナ（IBC）のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までの医薬品用中間バルクコンテナ（IBC）の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の医薬品用中間バルクコンテナ（IBC）の売上および2028年までの予測に焦点を当てています。

医薬品用中間バルクコンテナ（IBC）のグローバル主要企業には、Matcon、KIT Co,ltd、THIELMANN、GEA、Dec Group、SCHÄFER Werke GmbH、Premier Tech Ltd.、Ingredient Batching Systems Ltd、ISL Asia Technologies Pte. Ltd.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

医薬品用中間バルクコンテナ（IBC）市場は、タイプとアプリケーションによって区分されます。世界の医薬品用中間バルクコンテナ（IBC）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
ステンレス鋼IBC、ポリエチレンIBC

【アプリケーション別セグメント】
錠剤・カプセル、粉末、軟膏、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 医薬品用中間バルクコンテナ（IBC）製品概要
- タイプ別市場（ステンレス鋼IBC、ポリエチレンIBC）
- アプリケーション別市場（錠剤・カプセル、粉末、軟膏、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の医薬品用中間バルクコンテナ（IBC）販売量予測2017-2028
- 世界の医薬品用中間バルクコンテナ（IBC）売上予測2017-2028
- 医薬品用中間バルクコンテナ（IBC）の地域別販売量
- 医薬品用中間バルクコンテナ（IBC）の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別医薬品用中間バルクコンテナ（IBC）販売量
- 主要メーカー別医薬品用中間バルクコンテナ（IBC）売上
- 主要メーカー別医薬品用中間バルクコンテナ（IBC）価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模（ステンレス鋼IBC、ポリエチレンIBC）
- 医薬品用中間バルクコンテナ（IBC）のタイプ別販売量
- 医薬品用中間バルクコンテナ（IBC）のタイプ別売上
- 医薬品用中間バルクコンテナ（IBC）のタイプ別価格
・アプリケーション別市場規模（錠剤・カプセル、粉末、軟膏、その他）
- 医薬品用中間バルクコンテナ（IBC）のアプリケーション別販売量
- 医薬品用中間バルクコンテナ（IBC）のアプリケーション別売上
- 医薬品用中間バルクコンテナ（IBC）のアプリケーション別価格
・北米市場
- 北米の医薬品用中間バルクコンテナ（IBC）市場規模（タイプ別、アプリケーション別）
- 主要国別の医薬品用中間バルクコンテナ（IBC）市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの医薬品用中間バルクコンテナ（IBC）市場規模（タイプ別、アプリケーション別）
- 主要国別の医薬品用中間バルクコンテナ（IBC）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の医薬品用中間バルクコンテナ（IBC）市場規模（タイプ別、アプリケーション別）
- 主要国別の医薬品用中間バルクコンテナ（IBC）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の医薬品用中間バルクコンテナ（IBC）市場規模（タイプ別、アプリケーション別）
- 主要国別の医薬品用中間バルクコンテナ（IBC）市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの医薬品用中間バルクコンテナ（IBC）市場規模（タイプ別、アプリケーション別）
- 主要国別の医薬品用中間バルクコンテナ（IBC）市場規模（トルコ、サウジアラビア）
・企業情報
Matcon、KIT Co,ltd、THIELMANN、GEA、Dec Group、SCHÄFER Werke GmbH、Premier Tech Ltd.、Ingredient Batching Systems Ltd、ISL Asia Technologies Pte. Ltd.
・産業チェーン及び販売チャネル分析
- 医薬品用中間バルクコンテナ（IBC）の産業チェーン分析
- 医薬品用中間バルクコンテナ（IBC）の原材料
- 医薬品用中間バルクコンテナ（IBC）の生産プロセス
- 医薬品用中間バルクコンテナ（IBC）の販売及びマーケティング
- 医薬品用中間バルクコンテナ（IBC）の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 医薬品用中間バルクコンテナ（IBC）の産業動向
- 医薬品用中間バルクコンテナ（IBC）のマーケットドライバー
- 医薬品用中間バルクコンテナ（IBC）の課題
- 医薬品用中間バルクコンテナ（IBC）の阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Intermediate Bulk Container (IBC) for Pharmaceutical is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Intermediate Bulk Container (IBC) for Pharmaceutical is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Intermediate Bulk Container (IBC) for Pharmaceutical is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Intermediate Bulk Container (IBC) for Pharmaceutical include Matcon, KIT Co,ltd, THIELMANN, GEA, Dec Group, SCHÄFER Werke GmbH, Premier Tech Ltd., Ingredient Batching Systems Ltd and ISL Asia Technologies Pte. Ltd., etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Intermediate Bulk Container (IBC) for Pharmaceutical manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Intermediate Bulk Container (IBC) for Pharmaceutical market. Further, it explains the major drivers and regional dynamics of the global Intermediate Bulk Container (IBC) for Pharmaceutical market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Matcon
KIT Co,ltd
THIELMANN
GEA
Dec Group
SCHÄFER Werke GmbH
Premier Tech Ltd.
Ingredient Batching Systems Ltd
ISL Asia Technologies Pte. Ltd.
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Intermediate Bulk Container (IBC) for Pharmaceutical Segment by Type
Stainless Steel IBC
Polyethylene IBC
Intermediate Bulk Container (IBC) for Pharmaceutical Segment by Application
Tablet & Capsules
Powders
Ointments
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Intermediate Bulk Container (IBC) for Pharmaceutical market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Intermediate Bulk Container (IBC) for Pharmaceutical, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Intermediate Bulk Container (IBC) for Pharmaceutical, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Intermediate Bulk Container (IBC) for Pharmaceutical, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Intermediate Bulk Container (IBC) for Pharmaceutical sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Intermediate Bulk Container (IBC) for Pharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Intermediate Bulk Container (IBC) for Pharmaceutical sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Matcon, KIT Co,ltd, THIELMANN, GEA, Dec Group, SCHÄFER Werke GmbH, Premier Tech Ltd., Ingredient Batching Systems Ltd and ISL Asia Technologies Pte. Ltd., etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Intermediate Bulk Container (IBC) for Pharmaceutical in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Intermediate Bulk Container (IBC) for Pharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intermediate Bulk Container (IBC) for Pharmaceutical sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

レポート目次

1 Study Coverage
1.1 Intermediate Bulk Container (IBC) for Pharmaceutical Product Introduction
1.2 Market by Type
1.2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stainless Steel IBC
1.2.3 Polyethylene IBC
1.3 Market by Application
1.3.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Tablet & Capsules
1.3.3 Powders
1.3.4 Ointments
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Estimates and Forecasts 2017-2028
2.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Estimates and Forecasts 2017-2028
2.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Region
2.4.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Region (2017-2022)
2.4.2 Global Sales Intermediate Bulk Container (IBC) for Pharmaceutical by Region (2023-2028)
2.5 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region
2.5.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region (2017-2022)
2.5.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Manufacturers
3.1.1 Global Top Intermediate Bulk Container (IBC) for Pharmaceutical Manufacturers by Sales (2017-2022)
3.1.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intermediate Bulk Container (IBC) for Pharmaceutical in 2021
3.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Manufacturers
3.2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Manufacturers (2017-2022)
3.2.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Intermediate Bulk Container (IBC) for Pharmaceutical Revenue in 2021
3.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type
4.1.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Historical Sales by Type (2017-2022)
4.1.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Forecasted Sales by Type (2023-2028)
4.1.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Type (2017-2028)
4.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type
4.2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Historical Revenue by Type (2017-2022)
4.2.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Forecasted Revenue by Type (2023-2028)
4.2.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Type (2017-2028)
4.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Price by Type
4.3.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Price by Type (2017-2022)
4.3.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application
5.1.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Historical Sales by Application (2017-2022)
5.1.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Forecasted Sales by Application (2023-2028)
5.1.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Application (2017-2028)
5.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application
5.2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Historical Revenue by Application (2017-2022)
5.2.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Forecasted Revenue by Application (2023-2028)
5.2.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Application (2017-2028)
5.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Price by Application
5.3.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Price by Application (2017-2022)
5.3.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Price Forecast by Application (2023-2028)
6 North America
6.1 North America Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Type
6.1.1 North America Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2017-2028)
6.1.2 North America Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2017-2028)
6.2 North America Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Application
6.2.1 North America Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2017-2028)
6.2.2 North America Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2017-2028)
6.3 North America Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Country
6.3.1 North America Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2017-2028)
6.3.2 North America Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Type
7.1.1 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2017-2028)
7.1.2 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2017-2028)
7.2 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Application
7.2.1 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2017-2028)
7.2.2 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2017-2028)
7.3 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Country
7.3.1 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2017-2028)
7.3.2 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Type
8.1.1 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2017-2028)
8.1.2 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2017-2028)
8.2 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Application
8.2.1 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2017-2028)
8.2.2 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2017-2028)
8.3 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Region
8.3.1 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Region (2017-2028)
8.3.2 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Type
9.1.1 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2017-2028)
9.1.2 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2017-2028)
9.2 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Application
9.2.1 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2017-2028)
9.2.2 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2017-2028)
9.3 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Country
9.3.1 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2017-2028)
9.3.2 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Type
10.1.1 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2017-2028)
10.1.2 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2017-2028)
10.2 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Application
10.2.1 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2017-2028)
10.2.2 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2017-2028)
10.3 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Country
10.3.1 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2017-2028)
10.3.2 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Matcon
11.1.1 Matcon Corporation Information
11.1.2 Matcon Overview
11.1.3 Matcon Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Matcon Intermediate Bulk Container (IBC) for Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Matcon Recent Developments
11.2 KIT Co,ltd
11.2.1 KIT Co,ltd Corporation Information
11.2.2 KIT Co,ltd Overview
11.2.3 KIT Co,ltd Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 KIT Co,ltd Intermediate Bulk Container (IBC) for Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 KIT Co,ltd Recent Developments
11.3 THIELMANN
11.3.1 THIELMANN Corporation Information
11.3.2 THIELMANN Overview
11.3.3 THIELMANN Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 THIELMANN Intermediate Bulk Container (IBC) for Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 THIELMANN Recent Developments
11.4 GEA
11.4.1 GEA Corporation Information
11.4.2 GEA Overview
11.4.3 GEA Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GEA Intermediate Bulk Container (IBC) for Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GEA Recent Developments
11.5 Dec Group
11.5.1 Dec Group Corporation Information
11.5.2 Dec Group Overview
11.5.3 Dec Group Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dec Group Intermediate Bulk Container (IBC) for Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dec Group Recent Developments
11.6 SCHÄFER Werke GmbH
11.6.1 SCHÄFER Werke GmbH Corporation Information
11.6.2 SCHÄFER Werke GmbH Overview
11.6.3 SCHÄFER Werke GmbH Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 SCHÄFER Werke GmbH Intermediate Bulk Container (IBC) for Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 SCHÄFER Werke GmbH Recent Developments
11.7 Premier Tech Ltd.
11.7.1 Premier Tech Ltd. Corporation Information
11.7.2 Premier Tech Ltd. Overview
11.7.3 Premier Tech Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Premier Tech Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Premier Tech Ltd. Recent Developments
11.8 Ingredient Batching Systems Ltd
11.8.1 Ingredient Batching Systems Ltd Corporation Information
11.8.2 Ingredient Batching Systems Ltd Overview
11.8.3 Ingredient Batching Systems Ltd Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Ingredient Batching Systems Ltd Intermediate Bulk Container (IBC) for Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ingredient Batching Systems Ltd Recent Developments
11.9 ISL Asia Technologies Pte. Ltd.
11.9.1 ISL Asia Technologies Pte. Ltd. Corporation Information
11.9.2 ISL Asia Technologies Pte. Ltd. Overview
11.9.3 ISL Asia Technologies Pte. Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 ISL Asia Technologies Pte. Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ISL Asia Technologies Pte. Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intermediate Bulk Container (IBC) for Pharmaceutical Industry Chain Analysis
12.2 Intermediate Bulk Container (IBC) for Pharmaceutical Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intermediate Bulk Container (IBC) for Pharmaceutical Production Mode & Process
12.4 Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Marketing
12.4.1 Intermediate Bulk Container (IBC) for Pharmaceutical Sales Channels
12.4.2 Intermediate Bulk Container (IBC) for Pharmaceutical Distributors
12.5 Intermediate Bulk Container (IBC) for Pharmaceutical Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Intermediate Bulk Container (IBC) for Pharmaceutical Industry Trends
13.2 Intermediate Bulk Container (IBC) for Pharmaceutical Market Drivers
13.3 Intermediate Bulk Container (IBC) for Pharmaceutical Market Challenges
13.4 Intermediate Bulk Container (IBC) for Pharmaceutical Market Restraints
14 Key Findings in The Global Intermediate Bulk Container (IBC) for Pharmaceutical Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer